76 related articles for article (PubMed ID: 11030883)
1. Clostridium difficile toxins influence hepatocyte protein synthesis through the interleukin 1 receptor.
Mazuski JE; Grossmann EM; Norman JG; Denham W; Panesar N; Shapiro MJ; Durham RL; Kaminski DL; Longo WE
Arch Surg; 2000 Oct; 135(10):1206-11. PubMed ID: 11030883
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of Clostridium difficile toxins on hepatocytes.
Mazuski JE; Panesar N; Tolman K; Longo WE
J Surg Res; 1998 Oct; 79(2):170-8. PubMed ID: 9758734
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
4. Effects of cytokine antagonists on the hepatic acute-phase response.
Mazuski JE; Tolman K; Shapiro MJ
J Surg Res; 1997 Mar; 68(2):161-9. PubMed ID: 9184675
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
[TBL] [Abstract][Full Text] [Related]
6. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.
Dreikhausen U; Varga G; Hofmann F; Barth H; Aktories K; Resch K; Szamel M
Eur J Immunol; 2001 May; 31(5):1610-9. PubMed ID: 11465119
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.
Ng J; Hirota SA; Gross O; Li Y; Ulke-Lemee A; Potentier MS; Schenck LP; Vilaysane A; Seamone ME; Feng H; Armstrong GD; Tschopp J; Macdonald JA; Muruve DA; Beck PL
Gastroenterology; 2010 Aug; 139(2):542-52, 552.e1-3. PubMed ID: 20398664
[TBL] [Abstract][Full Text] [Related]
8. CD14 is an acute-phase protein.
Bas S; Gauthier BR; Spenato U; Stingelin S; Gabay C
J Immunol; 2004 Apr; 172(7):4470-9. PubMed ID: 15034063
[TBL] [Abstract][Full Text] [Related]
9. Hepatic acute phase protein synthesis is indirectly regulated by tumor necrosis factor.
Bankey PE; Mazuski JE; Ortiz M; Fulco JM; Cerra FB
J Trauma; 1990 Oct; 30(10):1181-7; discussion 1187-8. PubMed ID: 1698990
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
11. Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
Wang S; Rustandi RR; Lancaster C; Hong LG; Thiriot DS; Xie J; Secore S; Kristopeit A; Wang SC; Heinrichs JH
Vaccine; 2016 Mar; 34(10):1319-23. PubMed ID: 26614590
[TBL] [Abstract][Full Text] [Related]
12. Acute-phase hepatocytes regulate liver sinusoidal cell mediator production.
Bankey P; Prager M; Geldon D; Taylor S; McIntyre K
Arch Surg; 1994 Nov; 129(11):1166-71. PubMed ID: 7526821
[TBL] [Abstract][Full Text] [Related]
13. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
Yuan P; Zhang H; Cai C; Zhu S; Zhou Y; Yang X; He R; Li C; Guo S; Li S; Huang T; Perez-Cordon G; Feng H; Wei W
Cell Res; 2015 Feb; 25(2):157-68. PubMed ID: 25547119
[TBL] [Abstract][Full Text] [Related]
14. IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes.
Linevsky JK; Pothoulakis C; Keates S; Warny M; Keates AC; Lamont JT; Kelly CP
Am J Physiol; 1997 Dec; 273(6):G1333-40. PubMed ID: 9435559
[TBL] [Abstract][Full Text] [Related]
15. Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro.
Gauldie J; Sauder DN; McAdam KP; Dinarello CA
Immunology; 1987 Feb; 60(2):203-7. PubMed ID: 2434417
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice.
Lamacchia C; Palmer G; Bischoff L; Rodriguez E; Talabot-Ayer D; Gabay C
J Immunol; 2010 Aug; 185(4):2516-24. PubMed ID: 20639493
[TBL] [Abstract][Full Text] [Related]
18. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.
Warny M; Keates AC; Keates S; Castagliuolo I; Zacks JK; Aboudola S; Qamar A; Pothoulakis C; LaMont JT; Kelly CP
J Clin Invest; 2000 Apr; 105(8):1147-56. PubMed ID: 10772660
[TBL] [Abstract][Full Text] [Related]
19. Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins.
Pothoulakis C; Lamont JT
Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G178-83. PubMed ID: 11208538
[TBL] [Abstract][Full Text] [Related]
20. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment.
Mahida YR; Makh S; Hyde S; Gray T; Borriello SP
Gut; 1996 Mar; 38(3):337-47. PubMed ID: 8675084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
